Around 97% of patients with advanced pancreatic cancer die within five years. Researchers have figured out a way to target ...

New research is giving scientists a better understanding of the processes in the body that can lead to cancer.

GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and ...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest moments—revealing how lung cells with cancer-causing mutations recruit ...

Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole chromosomes, changes that help tumors grow, adapt and resist treatment. In ...

University of Virginia School of Medicine scientists have revealed how mistakes in the final step of cell division can have dire consequences for developing brain cells. The findings offer important ...

Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalized drugs that will keep patients living well for longer. A team ...

A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast ...

Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail because they don't stay in the body long enough to be effective or because they ...

We found four breast cancer risk prediction models that had been tested enough times to evaluate in detail. These were the Gail, Tyrer-Cuzick, BOADICEA, and BRCAPRO models. The BOADICEA model was one ...

Women taking GLP-1 drugs 30 percent less likely to develop breast cancer, researchers say - About 42,140 women are expected ...

Oral cancer in India is often diagnosed late due to symptom normalization among tobacco users, complicating treatment and ...